Cargando…
Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations
BACKGROUND: The issue of whether patients diagnosed with metastatic colorectal cancer who harbor KRAS codon 13 mutations could benefit from the addition of anti-epidermal growth factor receptor therapy remains under debate. The aim of the current study was to perform computational analysis to invest...
Autores principales: | Chen, Chih-Chieh, Er, Tze-Kiong, Liu, Yen-Yi, Hwang, Jenn-Kang, Barrio, Maria Jesus, Rodrigo, Maximiliano, Garcia-Toro, Enrique, Herreros-Villanueva, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577811/ https://www.ncbi.nlm.nih.gov/pubmed/23437064 http://dx.doi.org/10.1371/journal.pone.0055793 |
Ejemplares similares
-
KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies
por: Ottaiano, Alessandro, et al.
Publicado: (2023) -
Anti-Metastatic Activity of an Anti-EGFR Monoclonal Antibody against Metastatic Colorectal Cancer with KRAS p.G13D Mutation
por: Ohishi, Tomokazu, et al.
Publicado: (2020) -
Emergence of KRAS p.G13D mutation and acquired resistance to cetuximab in colorectal cancer with vulvar metastasis: A case report
por: Qiang, Weiguang, et al.
Publicado: (2019) -
Real-World Study of Characteristics and Treatment Outcomes Among Patients with KRAS p.G12C-Mutated or Other KRAS Mutated Metastatic Colorectal Cancer
por: Fakih, Marwan, et al.
Publicado: (2022) -
The role of CFTR p.G970D missense mutation in male infertility
por: Antonucci, Ivana, et al.
Publicado: (2022)